Index of reports
> Disability (9)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Torsemide disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Torsemide side effects in female
Reported by a physician from United States on 2012-07-02
Patient: female, weighing 180.0 kg (396.0 pounds)
Reactions: Diarrhoea, Anaphylactic Shock, Dermatitis Exfoliative
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Ibuprofen
Dosage: 2400 milligram;
Administration route: Oral
Start date: 2011-06-01
Rosuvastatin
Dosage: 20 milligram;
Administration route: Oral
Start date: 2011-06-01
Savella
Dosage: 50 milligram;
Administration route: Oral
Start date: 2011-09-10
End date: 2011-09-12
Omeprazole
Dosage: 20 milligram;
Administration route: Oral
Savella
Dosage: 12.5 milligram;
Administration route: Oral
Indication: Fibromyalgia
Start date: 2011-09-07
End date: 2011-09-07
Lovaza
Administration route: Oral
Start date: 2011-09-07
Torsemide
Dosage: 80 milligram;
Administration route: Oral
Start date: 2011-07-13
Other drugs received by patient: Metformin Hydrochloride; Potassium; Amoxicillin; Cinnamon; Vaccinium Macrocarpon; Bupropion HCL; Lisinopril; M.v.i.; Warfarin Sodium; Allopurinol; Amitriptyline HCL; Glimepiride; Propranolol; Fenofibrate; Oxybutynin; Colecalciferol; Vicodin; Phentermine Hydrochloride; Levothyroxine Sodium
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-14
Patient: male, weighing 130.0 kg (286.0 pounds)
Reactions: Dyspnoea, Refractory Anaemia, Diabetic Foot, Gout, Angina Pectoris, Impaired Work Ability, Left Ventricular Hypertrophy, Myelodysplastic Syndrome, Albumin Urine Present, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Torsemide
Dosage: 20 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-14
Diovan
Dosage: 160 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
End date: 2009-03-19
Lercanidipine
Dosage: 40 mg/d
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Diovan HCT
Dosage: 160/12.5 mg per day
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 320 mg,daily
Administration route: Oral
Start date: 2009-03-19
End date: 2011-01-10
Rasilez
Dosage: 300 mg daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-11-14
End date: 2012-02-15
Valsartan
Dosage: 320 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Doxazosin Mesylate
Dosage: 8 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-27
Other drugs received by patient: Diuretics; Insulin Human; Adenuric; Nebivolol HCL; Simvastatin; Aspirin; Humalog; Pantoprazole; Metformin HCL; Other Antihypertensives; Simvastatin
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-14
Patient: male, weighing 130.0 kg (286.0 pounds)
Reactions: Dyspnoea, Refractory Anaemia, Gout, Diabetic Foot, Angina Pectoris, Impaired Work Ability, Myelodysplastic Syndrome, Left Ventricular Hypertrophy, Albumin Urine Present, Hypertensive Crisis, Creatinine Urine Increased, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Diovan HCT
Dosage: 160/12.5 mg per day
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 160 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
End date: 2009-03-19
Valsartan
Dosage: 320 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Doxazosin Mesylate
Dosage: 8 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-27
Rasilez
Dosage: 300 mg daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-11-14
End date: 2012-02-15
Torsemide
Dosage: 20 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-14
Lercanidipine
Dosage: 40 mg/d
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Diovan
Dosage: 320 mg,daily
Administration route: Oral
Start date: 2009-03-19
End date: 2011-01-10
Other drugs received by patient: Aspirin; Pantoprazole; Other Antihypertensives; Simvastatin; Nebivolol HCL; Humalog; Simvastatin; Metformin HCL; Insulin Human; Adenuric; Diuretics
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-04
Patient: male, weighing 130.0 kg (286.0 pounds)
Reactions: Refractory Anaemia, Dyspnoea, Diabetic Foot, Gout, Angina Pectoris, Impaired Work Ability, Myelodysplastic Syndrome, Left Ventricular Hypertrophy, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Diovan HCT
Dosage: 1 df, unk
Administration route: Oral
Indication: Hypertension
Diovan
Dosage: 160 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
End date: 2009-03-19
Rasilez
Dosage: 300 mg daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-11-14
End date: 2012-02-15
Valsartan
Dosage: 320 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Torsemide
Dosage: 20 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-14
Doxazosin Mesylate
Dosage: 8 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-27
Lercanidipine
Dosage: 40 mg/d
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Diovan
Dosage: 320 mg,daily
Administration route: Oral
Start date: 2009-03-19
End date: 2011-01-10
Other drugs received by patient: Humalog; Adenuric; Metformin HCL; Simvastatin; Insulin Human; Simvastatin; Pantoprazole; Diuretics; Aspirin; Nebivolol HCL; Other Antihypertensives
Possible Torsemide side effects in male
Reported by a physician from Germany on 2012-05-04
Patient: male, weighing 130.0 kg (286.0 pounds)
Reactions: Dyspnoea, Refractory Anaemia, Angina Pectoris, Gout, Diabetic Foot, Impaired Work Ability, Left Ventricular Hypertrophy, Myelodysplastic Syndrome, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Rasilez
Dosage: 300 mg daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-11-14
End date: 2012-02-15
Diovan
Dosage: 160 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
End date: 2009-03-19
Torsemide
Dosage: 20 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-14
Diovan HCT
Dosage: 1 df, unk
Administration route: Oral
Indication: Hypertension
Valsartan
Dosage: 320 mg, qd
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Doxazosin Mesylate
Dosage: 8 mg, daily
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-27
Diovan
Dosage: 320 mg,daily
Administration route: Oral
Start date: 2009-03-19
End date: 2011-01-10
Carmen
Dosage: 40 mg/d
Administration route: Oral
Indication: Hypertension
Start date: 2007-04-20
Other drugs received by patient: Diuretics; Other Antihypertensives; Nebivolol HCL; Aspirin; Simvastatin; Pantoprazole; Metformin HCL; Insulin Human; Adenuric; Humalog; Simvastatin
Possible Torsemide side effects in 87 year old female
Reported by a physician from Japan on 2012-03-29
Patient: 87 year old female
Reactions: Vascular Insufficiency, Drug Ineffective, Oedema, Condition Aggravated, LEG Amputation, Hypertension
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Torsemide
Dosage: 8 mg (8 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Oedema
Start date: 2010-12-06
End date: 2010-12-24
Norvasc
Dosage: (7.5 mg), oral
Administration route: Oral
Indication: Hypertension
Anplag (Sarpogrelate Hydrochloride)
Dosage: (300 mg), oral
Administration route: Oral
Indication: Peripheral Arterial Occlusive Disease
Start date: 2010-11-23
Other drugs received by patient: Alprostadil; Pletal; Dorner (Beraprostsodium)
Possible Torsemide side effects in 87 year old female
Reported by a physician from Japan on 2012-03-29
Patient: 87 year old female
Reactions: Poor Peripheral Circulation, LEG Amputation
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Torsemide
Administration route: Oral
Indication: Oedema
Start date: 2010-12-06
End date: 2010-12-24
Sarpogrelate
Administration route: Oral
Indication: Peripheral Arterial Occlusive Disease
Start date: 2010-11-23
Amlodipine Besylate
Administration route: Oral
Indication: Hypertension
Other drugs received by patient: Alprostadil; Dorner; Pletal
Possible Torsemide side effects in 87 year old female
Reported by a physician from Japan on 2012-03-19
Patient: 87 year old female
Reactions: Poor Peripheral Circulation, LEG Amputation
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Sarpogrelate
Administration route: Oral
Indication: Peripheral Arterial Occlusive Disease
Start date: 2010-11-23
Amlodipine Besylate
Administration route: Oral
Indication: Hypertension
Torsemide
Administration route: Oral
Indication: Oedema
Start date: 2010-12-06
End date: 2010-12-24
Other drugs received by patient: Dorner; Pletal; Alprostadil
Possible Torsemide side effects in 87 year old female
Reported by a physician from Japan on 2012-03-13
Patient: 87 year old female
Reactions: Intermittent Claudication, Pain, Oedema, Hypoaesthesia, LEG Amputation, Gait Disturbance, Feeling Cold
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Anplag (Sarpogrelate Hydrochloride)
Dosage: (300 m), oral
Administration route: Oral
Indication: Peripheral Arterial Occlusive Disease
Start date: 2010-11-23
Torsemide
Dosage: 8 mg (8 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Oedema
Start date: 2010-12-06
End date: 2010-12-24
Norvasc
Dosage: (7.5 mg), oral
Administration route: Oral
Indication: Hypertension
Other drugs received by patient: Pletal; Dorner (Beraprost Sodium); Paulux (Alprostadil)
|